Aditxt, Inc. Fair Value Adjustment of Warrants
Aditxt, Inc. (ADTX) reported Fair Value Adjustment of Warrants of $11.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2026-05-20
- Aditxt, Inc. fair value adjustment of warrants for the quarter ending 2026-03-31 was $11.80M.
- Aditxt, Inc. fair value adjustment of warrants for the quarter ending 2025-12-31 was -$228.00.
- Aditxt, Inc. fair value adjustment of warrants for the quarter ending 2025-09-30 was -$162.00.
- Aditxt, Inc. fair value adjustment of warrants for the quarter ending 2025-06-30 was -$980.00.
- Aditxt, Inc. fair value adjustment of warrants for fiscal 2025 was -$14.52K.
- Aditxt, Inc. fair value adjustment of warrants for fiscal 2024 was -$414.50K.
| Period end | Fair Value Adjustment of Warrants 0 month | Fair Value Adjustment of Warrants 1 month | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11.80M 10-Q · filed 2026-05-20 | $11.80M derived: sum of 2 quarters · filed 2026-05-20 | $11.80M derived: sum of 3 quarters · filed 2026-05-20 | $11.80M derived: sum of 4 quarters · filed 2026-05-20 | ||
| 2025-12-31 | -$228.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$390.00 derived: sum of 2 quarters · filed 2026-03-31 | -$1.37K derived: sum of 3 quarters · filed 2026-03-31 | -$14.52K 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$162.00 10-Q · filed 2025-11-18 | -$1.14K derived: sum of 2 quarters · filed 2025-11-18 | -$14.29K 10-Q · filed 2025-11-18 | |||
| 2025-06-30 | -$980.00 10-Q · filed 2025-08-14 | -$14.13K 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | -$13.14K 10-Q · filed 2026-05-20 | |||||
| 2024-12-31 | -$414.50K 10-K · filed 2026-03-31 | |||||
| 2022-06-15 | $3.76M 10-K · filed 2023-04-17 | |||||
| 2021-06-30 | $185.85K 10-Q · filed 2021-08-12 | |||||
| 2021-01-25 | $231.32K 10-K · filed 2022-03-31 | |||||
| 2020-06-30 | $30.98K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |